Zen Technologies Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
ZENTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zen Technologies Limited has filed its QIP fund utilization statement for Q4 FY2026. The company raised Rs. 979.51 Crores (net of expenses) through a Qualified Institutional Placement in August 2024, issuing 62,46,096 equity shares at Rs. 1,601 per share (face value Rs. 1 with Rs. 1,600 premium). The funds were allocated across three purposes: working capital (Rs. 410 Crores), inorganic growth/acquisitions (Rs. 350 Crores), and general corporate purposes (Rs. 219.51 Crores). The statement confirms NO deviation or variation in fund utilization. CRISIL Ratings Limited is the monitoring agency. Funds deployed so far: Rs. 410 Crores for working capital, Rs. 171.42 Crores for acquisitions, and Rs. 122.34 Crores for general corporate purposes.
No immediate shareholder concern as the company has confirmed proper utilization of QIP proceeds with no deviations reported. The incomplete deployment for acquisitions and corporate purposes indicates ongoing strategic initiatives.